Q3 2024 |
56 |
$3.53B |
+$131M |
-$46.7M |
+$84.4M |
BKNG, EXPE, SYF, WEX, UBER
|
13F-HR |
11/14/2024, 03:44 PM |
Q2 2024 |
50 |
$3.18B |
+$126M |
-$18.9M |
+$107M |
BKNG, SYF, EXPE, WEX, UBER
|
13F-HR |
8/14/2024, 03:56 PM |
Q1 2024 |
47 |
$3.22B |
+$229M |
-$294M |
-$65.5M |
BKNG, WEX, EXPE, SYF, UBER
|
13F-HR |
5/15/2024, 03:50 PM |
Q4 2023 |
42 |
$3.04B |
+$103M |
-$249M |
-$147M |
EXPE, BKNG, WEX, UBER, SYF
|
13F-HR |
2/14/2024, 03:44 PM |
Q3 2023 |
47 |
$2.67B |
+$84.7M |
-$82.2M |
+$2.55M |
BKNG, EXPE, WEX, UBER, SYF
|
13F-HR |
11/14/2023, 03:46 PM |
Q2 2023 |
45 |
$2.87B |
+$78.9M |
-$264M |
-$185M |
EXPE, WEX, BKNG, UBER, SYF
|
13F-HR |
8/14/2023, 03:45 PM |
Q1 2023 |
42 |
$2.72B |
+$133M |
-$484M |
-$351M |
WEX, EXPE, BKNG, UBER, SYF
|
13F-HR |
5/15/2023, 03:34 PM |
Q4 2022 |
39 |
$2.78B |
+$168M |
-$245M |
-$77M |
EXPE, WEX, BKNG, SYF, UBER
|
13F-HR |
2/14/2023, 03:58 PM |
Q3 2022 |
42 |
$2.7B |
+$303M |
-$513M |
-$210M |
EXPE, UBER, WEX, BKNG, SYF
|
13F-HR |
11/14/2022, 03:56 PM |
Q2 2022 |
40 |
$2.98B |
+$400M |
-$351M |
+$48.9M |
EXPE, BKNG, WEX, UBER, SYF
|
13F-HR |
8/15/2022, 03:31 PM |
Q1 2022 |
47 |
$4.18B |
+$761M |
-$335M |
+$426M |
EXPE, BKNG, TRIP, WEX, UBER
|
13F-HR |
5/16/2022, 03:46 PM |
Q4 2021 |
56 |
$3.7B |
+$233M |
-$442M |
-$209M |
EXPE, SYF, TRIP, BKNG, WEX
|
13F-HR |
2/14/2022, 03:21 PM |
Q3 2021 |
61 |
$4.17B |
+$448M |
-$141M |
+$308M |
EXPE, BKNG, TRIP, SYF, WEX
|
Restatement |
11/15/2021, 05:21 PM |
Q2 2021 |
60 |
$4.02B |
+$271M |
-$131M |
+$139M |
EXPE, TRIP, SYF, BKNG, UAL
|
13F-HR |
8/16/2021, 03:45 PM |
Q1 2021 |
46 |
$4.23B |
+$333M |
-$498M |
-$165M |
TRIP, EXPE, BKNG, SYF, UAL
|
13F-HR |
5/17/2021, 03:56 PM |
Q4 2020 |
30 |
$3.43B |
+$508M |
-$551M |
-$42.8M |
EXPE, BKNG, TRIP, UAL, SYF
|
13F-HR |
2/16/2021, 03:16 PM |
Q3 2020 |
43 |
$2.64B |
+$266M |
-$518M |
-$253M |
BKNG, UAL, EXPE, SYF, CHDN
|
13F-HR |
11/16/2020, 03:01 PM |
Q2 2020 |
46 |
$2.61B |
+$262M |
-$526M |
-$264M |
BKNG, UAL, EXPE, DVA, SYF
|
13F-HR |
8/14/2020, 03:12 PM |
Q1 2020 |
45 |
$2.32B |
+$355M |
-$824M |
-$469M |
BKNG, DVA, UAL, EXPE, ALGT
|
13F-HR |
5/15/2020, 02:51 PM |
Q4 2019 |
43 |
$5.14B |
+$199M |
-$811M |
-$611M |
UAL, EXPE, BKNG, DVA, ALGT
|
13F-HR |
2/14/2020, 11:35 AM |
Q3 2019 |
49 |
$5.75B |
+$74M |
-$196M |
-$122M |
EXPE, UAL, DAL, BKNG, CHDN
|
13F-HR |
11/14/2019, 03:21 PM |
Q2 2019 |
50 |
$5.96B |
+$380M |
-$272M |
+$108M |
UAL, EXPE, DAL, BKNG, CHDN
|
13F-HR |
8/14/2019, 03:01 PM |
Q1 2019 |
49 |
$5.39B |
+$344M |
-$1.05B |
-$703M |
UAL, EXPE, DAL, BKNG, ALGT
|
13F-HR |
5/15/2019, 03:03 PM |
Q4 2018 |
60 |
$5.98B |
+$505M |
-$2.06B |
-$1.56B |
UAL, EXPE, DAL, BKNG, LUV
|
13F-HR |
2/14/2019, 03:29 PM |
Q3 2018 |
77 |
$8.71B |
+$679M |
-$1.41B |
-$734M |
UAL, EXPE, DAL, MCK, LUV
|
13F-HR |
11/14/2018, 03:06 PM |
Q2 2018 |
82 |
$8.89B |
+$255M |
-$739M |
-$484M |
UAL, EXPE, DAL, MCK, GRUB
|
13F-HR |
8/14/2018, 01:34 PM |
Q1 2018 |
82 |
$9.11B |
+$993M |
-$778M |
+$215M |
UAL, EXPE, DAL, MCK, GRUB
|
13F-HR |
5/15/2018, 03:04 PM |
Q4 2017 |
78 |
$8.95B |
+$386M |
-$845M |
-$459M |
UAL, EXPE, DAL, MCK, GRUB
|
13F-HR |
2/14/2018, 03:02 PM |
Q3 2017 |
82 |
$8.8B |
+$496M |
-$451M |
+$45.1M |
UAL, EXPE, DAL, MCK, GRUB
|
13F-HR |
11/14/2017, 03:14 PM |
Q2 2017 |
84 |
$8.9B |
+$533M |
-$723M |
-$190M |
UAL, EXPE, DAL, MCK, CI
|
13F-HR |
8/14/2017, 02:48 PM |
Q1 2017 |
77 |
$8.23B |
+$853M |
-$381M |
+$473M |
UAL, EXPE, DAL, CI, ALK
|
13F-HR |
5/15/2017, 03:13 PM |
Q4 2016 |
75 |
$7.65B |
+$438M |
-$270M |
+$168M |
UAL, EXPE, DAL, CI, ALK
|
13F-HR |
2/14/2017, 03:59 PM |
Q3 2016 |
84 |
$6.92B |
+$418M |
-$154M |
+$265M |
UAL, EXPE, DAL, CI, ALK
|
13F-HR |
11/14/2016, 03:43 PM |
Q2 2016 |
80 |
$6.03B |
+$700M |
-$431M |
+$269M |
EXPE, UAL, DAL, CI, ALK
|
13F-HR |
8/15/2016, 03:03 PM |
Q1 2016 |
79 |
$6.24B |
+$1.65B |
-$742M |
+$911M |
UAL, DAL, EXPE, ALK, CI
|
13F-HR |
5/16/2016, 01:05 PM |
Q4 2015 |
80 |
$5.43B |
+$562M |
-$175M |
+$388M |
DAL, EXPE, UAL, ALK, ENT
|
13F-HR |
2/16/2016, 01:57 PM |
Q3 2015 |
80 |
$4.74B |
+$758M |
-$207M |
+$551M |
DAL, EXPE, ALK, ENT, UAL
|
13F-HR |
11/16/2015, 01:01 PM |
Q2 2015 |
73 |
$4.42B |
+$425M |
-$208M |
+$218M |
DAL, EXPE, ENT, ALK, CHDN
|
13F-HR |
8/14/2015, 11:34 AM |
Q1 2015 |
70 |
$4.33B |
+$347M |
-$492M |
-$145M |
DAL, ENT, EXPE, ALK, AAL
|
13F-HR |
5/15/2015, 02:08 PM |
Q4 2014 |
70 |
$4.33B |
+$714M |
-$456M |
+$258M |
DAL, ENT, EXPE, ALK, LUV
|
13F-HR |
2/17/2015, 03:49 PM |
Q3 2014 |
68 |
$3.74B |
+$559M |
-$208M |
+$351M |
ENT, EXPE, DAL, PCLN, ALK
|
13F-HR |
11/14/2014, 02:07 PM |
Q2 2014 |
64 |
$3.62B |
+$460M |
-$190M |
+$270M |
ENT, EXPE, PCLN, TRIP, ALK
|
13F-HR |
8/14/2014, 01:26 PM |
Q1 2014 |
64 |
$3.31B |
+$443M |
-$389M |
+$53.9M |
ENT, ALK, EXPE, TRIP, DAL
|
13F-HR |
5/15/2014, 12:48 PM |
Q4 2013 |
55 |
$3B |
$0 |
$0 |
|
ENT, PCLN, CAR, TRIP, ALK
|
13F-HR |
2/14/2014, 03:15 PM |